Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Carcinoma × lorlatinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Carcinoma, Non-Small-Cell Lung 2 NSCLC 1 Meningeal Carcinomatosis 1 Carcinoma 1 Brain Neoplasms 1 Advanced Non-Small Cell Lung Cancer 1

Interventions

lorlatinib 1 elemene 1 capmatinib 1 aumolertinib 1 aflutinib 1 Technetium Tc 99m Aggregated Albumin 1 Sunitinib 1 Sevoflurane 1 Radiotherapy 1 Propofol 1 Gefitinib 1 Craniotomy 1 Carboplatin 1 Albumin-Bound Paclitaxel 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04362072 2025-06-11

Study of Lorlatinib In People With ALK-positive Non-small Cell Lung Cancer

Pfizer

Phase 4 Completed

71 enrolled 26 charts

Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡